Caspase-Cleavage of Tau in Alzheimer's Disease

About the Research Project
Program
Award Type
Pilot
Award Amount
$131,140
Active Dates
April 01, 2007 - March 31, 2010
Grant ID
A2007316
Acknowledgement
Co-Principal Investigator(s)
Wayne Poon, PhD, University of California - Irvine
Goals
Direct, functional evidence for the involvement of caspases in driving AD pathology is currently lacking. The current proposal will test directly the role of caspases in AD by blocking caspase activation in an AD transgenic mouse model and examining whether such inhibition prevents the pathology associated with these animals.
Summary
Introduction: Recent studies have suggested that proteolytic cleavage of tau by caspases may be an important event linking beta-amyloid with neurofibrillary tangles in Alzheimer’s disease (AD). These studies suggest that caspase activation may play an important role in driving AD disease pathology and simply do not represent end-stage events associated with this disease. Hypothesis: Direct, functional evidence for the involvement of caspases in driving AD pathology is currently lacking. The current proposal will test directly the role of caspases in AD by blocking caspase activation in an AD transgenic mouse model and examining whether such inhibition prevents the pathology associated with these animals. Specific Aim 1: Crossing 3xTg-AD mice with Bcl-2 OE Tg mice will prevent the caspase cleavage of tau Specific Aim 2: Mice resulting from crossing 3xTg-AD mice with Bcl-2 OE Tg mice will exhibit fewer tangle alterations. Long-term goals: Direct evidence indicating a causative role for caspases in AD may stimulate the development of caspase inhibitors for their potential in treating this disease. In addition, results from this pilot study will provide the necessary feasibility and data for the development of a more comprehensive proposal examining all pathological aspects of these novel AD mice.
Grants
Related Grants
Alzheimer's Disease Research
Tau, Aβ, and Network Degeneration in Alzheimer’s Disease
Active Dates
July 01, 2014 - June 30, 2017
Principal Investigator
Rik Ossenkoppele, PhD
Tau, Aβ, and Network Degeneration in Alzheimer’s Disease
Active Dates
July 01, 2014 - June 30, 2017

Principal Investigator
Rik Ossenkoppele, PhD
Alzheimer's Disease Research
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022
Principal Investigator
Hyunjun Yang, PhD
Fingerprinting In Vivo and In Vitro Prion Strains
Active Dates
September 01, 2020 - November 30, 2022

Principal Investigator
Hyunjun Yang, PhD
Alzheimer's Disease Research
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015
Principal Investigator
Guojun Bu, PhD
Partnership with Molecular Neurodegeneration Open Access Journal
Active Dates
July 01, 2010 - June 30, 2015

Principal Investigator
Guojun Bu, PhD